Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing number of surgical procedures globally
3.2.1.2 Increasing incidence of accidents and trauma cases
3.2.1.3 Rising technological advancements in hemostasis products
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of products
3.2.2.2 Availability of alternatives
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Origin, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Bovine
5.3 Porcine
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 General surgery
6.3 Cardiovascular surgery
6.4 Orthopedic surgery
6.5 Gynecological surgery
6.6 Neurosurgery
6.7 Reconstructive surgery
6.8 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals & clinics
7.3 Ambulatory surgical centers
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 3D Matrix Medical Technology
9.2 Aegis Lifesciences Private Limited
9.3 Baxter International Inc.
9.4 CR Bard Inc. (Becton, Dickinson, and Company)
9.5 Ethicon, Inc. (Johnson & Johnson)
9.6 Ferrosan Medical Devices A/S
9.7 Integra LifeSciences Corporation
9.8 Medcura Inc.
9.9 Pfizer, Inc.
9.10 Teleflex Incorporated
